Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07361354
PHASE1
A Phase 1 Ethnobridging TriaL of AGA2118 in Healthy Japanese, Chinese, and Caucasian ParticipantS (ATLAS)
Sponsor: Angitia Incorporated Limited
View on ClinicalTrials.gov
Summary
This study will evaluate the effects of a single dose of AGA2118 in Japanese, Chinese, and Caucasian participants
Official title: A Phase 1, Randomized, Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics of AGA2118 in Healthy Japanese, Chinese, and Caucasian Participants
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2026-01-05
Completion Date
2026-11
Last Updated
2026-01-23
Healthy Volunteers
Yes
Interventions
DRUG
AGA2118
Participants will receive AGA2118 administered by subcutaneous injection
Locations (1)
Los Angeles EPCU
Glendale, California, United States